Affiliation:
1. Muğla Education and Research Hospital Obstetrics and Gynecology Department
2. MUGLA SITKI KOCMAN UNIVERSITY
3. Milas State Hospital
Abstract
To determine the rate of seropositivity in toxoplasma, rubella and cytomegalovirus infections during pregnancy. 4488 pregnants who applied to outpatient polyclinics of Gynecology and Obstetrics in Muğla Sıtkı Koçman University Training and Research Hospital for pregnancy examination in the first 10 weeks of pregnancy were included in the study. Results of anti-Toxoplasma IgM and IgG, anti-Rubella IgM and IgG, anti-CMV IgM and IgG were evaluated. Seropositivity rates of anti-Toxoplasma, anti-Rubella, anti-CMV IgG and IgM were determined respectively 21.6%, 1.6%, 92.8%, 1%; 98.5%, 1.1% in the study group. Toxoplasma, Rubella and CMV seroprevalence should be evaluated during preconceptional or antenatal screening according to regional conditions.
Publisher
Mugla Sitki Kocman University
Reference21 articles.
1. 1. Yadav RK, Maity S, Saha S. A review on TORCH: groups of congenital infection during pregnancy. J Sci In Res. 2014;3(2):258-64.
2. 2. Newton ER. Diagnosis of perinatal TORCH infections. Clin Obstet Gynecol. 1999;42(1):59-70.
3. 3. Tamer GS, Dundar D, Caliskan E. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey. Clin Invest Med. 2009;32(1):43-7.
4. 4. Abdel Fattah SA, Bhat A, Illanes S, et al. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn. 2005;25(11):1028-31.
5. 5. Kasap B, Öner G, Küçük M, et al. Muğla’daki gebelerin toksoplazma, rubella, sitomegalovirüs ve hepatit prevalansının değerlendirilmesi. Tepecik Eğit Araşt Hast Derg. 2017;27(1):31-6.